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Abstract Deuterated rhamnolipids were produced using
strain AD7 of Pseudomonas aeruginosa, which was progres-
sively adapted to increasing levels of deuterium in D2O and
carbon substrates. Fourteen different deuterated rhamnolipid
structures, including structural isomers, were produced
which is similar to normal protonated structures. There were
two main products monorhamnolipid Rha-C10-C10 and
dirhamnolipid Rha2-C10-C10. The levels of deuteration
varied from 16% with 25% D2O + h-glycerol to 90% with
100% D2O + d-glycerol. When d-tetradecane was used with
H2O, virtually all the deuterium appeared in the lipid chains
while using h-tetradecane + D2O led to the majority of
deuterium in the sugars. The adaptation to growth in
deuterium appeared to be metabolic since no genetic changes
could be found in the key rhamnolipid biosynthetic genes,
the rhamnosyl transferases RhlB and RhlC. Deuterated
sophorolipids were similarly produced using Candida
bombicola and Candida apicola although in this case, no
adaptation process was necessary. Up to 40 different
sophorolipids were produced by these yeasts. However,
unlike the rhamnolipids, use of D2O did not lead to any
deuteration of the lipid chains, but direct incorporation
into the lipid was achieved using d-isostearic acid. The
results from these experiments show the feasibility of
producing deuterated bioactive compounds from micro-
organisms coupled with the possibility of manipulating the
pattern of labelling through judicious use of different
deuterated substrates.
Keywords Deuterium . Deuterated . Biosurfactants .
Bioactives . Rhamnolipids . Sophorolipids
Introduction
Isotopes of many of the biologically important elements
have been used extensively for labelling and tracing
metabolic pathways, either using radionuclides or heavy
isotopes. These tracing methods are predicated on the view
that the presence of alternative isotopes of elements does
not disrupt the metabolic patterns of organisms, particularly
microorganisms. Since the alternative isotopes often form
only a small proportion of the total, as detection methods
are highly sensitive, this assumption is normally true.
However, the situation changes when dealing with
deuterium ions otherwise known as ‘heavy hydrogen’, a
stable isotope of hydrogen. When deuterium labelling of
metabolites is required for neutron beam scattering
(Russell et al. 2007) or NMR studies (Morgan et al.
2000), highly deuterated precursors are provided to
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organisms to obtain a high level of deuteration. Under
these conditions, early studies noted no effect of D2O on
bacteria up to about 20% (De Giovanni and Zamenhof
1963; Thomson 1963), but at higher concentrations,
growth rates were decreased significantly. Methods were
subsequently developed to adapt or ‘train’ organisms to
increasing levels of deuterated substrates in an effort to
produce labelled products (Paliy et al. 2003; Newo et al.
2004). An alternative approach was employed with
Chlorella vulgaris using alkylating agents to produce
mutant strains which were able to tolerate deuterium
(Unno et al. 2005) More recent work has focussed on trying
to manipulate deuterium labelling in polyhydroxyoctanoate
produced by Pseudomonas oleovorans for neutron scattering
studies (Foster et al. 2006; Russell et al. 2007; Holden et al.
2008). Overall, interest in producing deuterated metabolites
in microorganisms has been limited since their only
application appeared to be for basic research studies (Myles
2006), but this is an area of increasing interest. There has
also been renewed interest in this area, however, with the
realisation that deuterated products may have specific
biotechnological potential (Kushner et al. 1999), particularly
in the pharmacology field where deuterated drugs may have
a longer residence time in the body and with lower metabolic
rates may be less toxic.
Research interest in our laboratories has focussed on
biosurfactants as amphiphilic compounds with both hydro-
philic and hydrophobic moieties able to help the producing
microorganisms solubilise hydrophobic substrates (Desai and
Banat 1997; Banat et al. 2000, 2010; Satpute et al. 2010;
Perfumo et al. 2010a, b; Franzetti et al. 2010). As part of an
investigation of the surface interactions of biosurfactant
using neutron reflectivity (Lu et al. 2000), we undertook to
produce deuterated, rhamnolipids from P. aeruginosa and
subsequently deuterated sophorolipids from the yeast C.
apicola. Since our objective was to produce extensively
labelled products with various alternative labelling patterns
of the hydrophobic and hydrophilic portions of the mole-
cules, we employed both deuterated water and deuterated
carbon substrates. From this work, we can identify a strategy
that may have wider application for the directed labelling of
bioactive molecules with vast potential future applications.
Materials and methods
Organisms and growth media
The organisms used in this study were P. aeruginosa
AD7 isolated from hydrothermal water (Perfumo et al.
2006), C. bombicola ATCC 22214 and C. apicola ATCC
96134. P. aeruginosa was routinely cultivated in LB broth
(shaken at 200 rpm) or streaked on agar plates, all
incubations were at 37°C. The production medium for
rhamnolipids was a mineral salts medium21 with 2% (v/v)
glycerol or tetradecane. The Candida strains were main-
tained on YM medium (C. bombicola) or YEPD medium (C.
apicola) and incubated at 27°C. The production medium for
sophorolipids (GYU) contained (g/l) glucose 100, yeast
extract 10, urea 1, incubated at 200 rpm and 27°C. Cells
were grown on GYU for 36–48 h (growth phase) before the
second carbon substrate (2% v/v isostearic acid or oleic acid)
was added (production phase). Various deuterated substrates
were used for the production of deuterated rhamnolipids and
sophorolipids. Deuterated water was used as the basis for the
growth medium with deuterated glycerol, deuterated tetrade-
cane used for rhamnolipid production and deuterated
isostearic acid used for sophorolipid production.
P. aeruginosa displayed significant growth inhibition
when challenged with deuterated medium, containing either
deuterated water or carbon substrate. To overcome the
inhibition, the strain was ‘trained’ using a regime of
increasing deuterium concentration separately in the water
and carbon substrate. The regime for adaptation to
deuterium was as follows: D2O–H2O 25:75 2 days, 50:50
2 days, 75:25 3 days, 90:10 4 days, 100:0 5 days.
Extraction procedures
Deuterated rhamnolipids were extracted by centrifuging the
culture broth at 15,000×g for 15 min to remove cells. The
pH was then adjusted to 2.0 using concentrated HCl
followed by extraction with an equal amount of ethyl
acetate (repeated four times). The ethyl acetate extract was
dried over magnesium sulphate and rotary evaporated to
yield a brown gum extract. Solid phase extraction was
carried out using Silica SPE strata cartridges (Phenomenex,
UK) to remove non-polar impurities co-extracted. SPE
cartridges were conditioned with chloroform and the
extracts applied and washed with chloroform removing
non-polar lipids, followed by elution of rhamnolipids using
50:50 (v/v) chloroform–methanol. The purified glycolipids
were evaporated to dryness and dissolved in methanol prior
to HPLC–MS analysis.
Extractions of deuterated sophorolipids were carried out
in a similar manner to rhamnolipids above, without
acidification since the low aqueous solubility of sophoro-
lipids allows the material to separate directly. Once dried,
excess co-extracted carbon source was removed by washing
three times with hexane. Other non-polar impurities were
removed using the SPE method as described above.
Analytical characterisation
HPLC–MS characterisation of the glycolipids was achieved
using the LCQTM quadrupole ion-trap mass spectrometer
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(Finnigan MAT, San Jose, CA, USA) utilising ESI
connected to a thermo spectra HPLC system. Tandem mass
spectrometry was carried out using collision energy of 35%
throughout on the most intense peak in each MS scan. The
scan range was set at m/z 50–800, with sheath gas flow set
to 65 and the auxiliary gas to 35. The spray voltage was set
to 3.5 kV and the capillary temperature to 250°C. Nitrogen
gas was delivered from a Whatman nitrogen generator
(Whatman Inc. Haverhill, MA, USA), with the helium
damping gas (99.999% purity) present in the ion trap
obtained from BOC Medical Gases (Guildford, Surrey,
UK). HPLC–MS separation of the rhamnolipid mixtures
utilised a reverse phase C18 column (Luna 5 μm C18, 250×
4.6 mm, Phenomenex) and a binary gradient mobile phase
comprising HPLC grade H2O (BDH, Dorset, UK) as
mobile phase A and acetonitrile (BDH, Dorset, UK) as
mobile phase B. Initially, the proportions were 70% A, 30%
B, adjusted in a linear gradient to 30% A, 70% B over
50 min and then back to 70% A, 30% B by 55 min and held
for 5 min. The flow rate of 0.5 ml min−1 and an injection
volume of 20 μl were used throughout.
Sophorolipid analysis was carried out using the same
procedure as above with the following difference in the
HPLC method. HPLC was performed using a reverse phase
C18 column (Gemini 5 μm C18, 250×4.6 mm, Phenomenex)
and a binary gradient mobile phase comprising HPLC grade
H2O as mobile phase A and acetonitrile as mobile phase B.
Initially, the proportions were 40% A, 60% B, adjusted in a
linear gradient to 10% A, 90% B over 55 min and then back
to 40% A, 60% B by 57 min and held for 3 min. The flow
rate of 0.5 ml min−1 and an injection volume of 20 μl were
used throughout.
Molecular methods
Deuterium-adapted cells of P. aeruginosa AD7, designated
AD7-d, were harvested from deuterated medium, pelleted
and the genomic DNA extracted. The two rhamnosyl
transferase genes RhlB and RhlC were selected for
sequence comparison. The methods for DNA extraction,
PCR (including primer sequences) and sequencing and
subsequent bioinformatics handling of data are as follows.
Genomic DNA was extracted using a commercial Fast
DNA® Spin® Kit for Soil (BIO101, Carlsbad, CA), and
cell lysis was performed with a FastPrep™ FP120 cell
disrupter. PCR amplification of full-length rhlB and rhlC
genes was carried out using newly designed sets of primers
as follows:
rhlB2-f CATTTCCTCGACCTGGAGTC rhlB2-r
ATCGAGAAAGCGTTGCAGTT
rhlB3-f GGTACACCCCAAGTTCAACG rhlB3-r
AAAAAGCCTCCGTCATTCCT
rhlC2-f CTCGTCATTCTGGCTGGTCT rhlC2-r
GCAGGCTGTATTCGGTGTC
rhlC3-f ATCCATCTCGACGGACTGAC rhlC3-r
GGGCGATTCGTTCTACTTCC.
PCRs were performed using the GC-RICH PCR system-
dNTPack (Roche) with MgCl2 concentration adjusted to
2.5 mM. The PCR cycle was as follows: initial denaturation
at 95°C for 3 min, 30 cycles of denaturation at 95°C for
60 s, annealing at 56°C for 60 s, extension at 72°C for 90 s
and final extension at 72°C for 10 min. Sequencing
reactions were prepared using an ABI Prism® BigDye™
Terminator reaction kit (Applied Biosystems, Foster City,
CA) with addition of 5% (v/v) dimethyl sulfoxide and run
on an ABI Prism® 3100 Genetic Analyzer (Applied
Biosystems). Each gene was sequenced in both forward
and reverse direction with external and internal primers to
produce overlapping fragments. Full-length sequences were
obtained by assembling fragments with the CAP3
programme and for each gene forward and reverse contigs
were aligned with ClustalW 2.0 to validate nucleotide
match.
Results
Despite the adaptation, growth and rhamnolipid produc-
tion in the fully deuterated medium was considerably
lower than in non-deuterated medium. The Candida
strains did not require any training regime to grow in
deuterated media. The major results from the deuteration
experiments for rhamnolipid and sophorolipid production
are displayed in Tables 1 and 2, respectively. Analysis of
the deuterated rhamnolipids produced in each experiment
using HPLC-MS revealed the presence of up to 14
different structures including structural isomers, which is
also generally observed during production of protonated
rhamnolipids. Due to the complexity of the sample, only
the main monorhamnolipid, L-rhamnosyl-β-hydroxydeca-
noyl-β-hydroxydecanoate designated as Rha-C10-C10 and
the main dirhamnolipid, L-rhamnosyl-L-rhamnosyl-β-
hydroxydecanoyl-β-hydroxydecanoate designated as
Rha2-C10-C10 are displayed in the table. Rha-C10-C10 has
a molecular formula of C26H48O9 and under ESI-MS
conditions using negative mode ionisation gives an [M–H]−
signal at m/z 503, representing the loss of a proton from the
molecular mass of the compound during ionisation. Rha2-
C10-C10 contains a dirhamnose sugar attached to the fatty
acid chain and displays an [M–H]− signal at m/z 649 in the
non-deuterated form and corresponds to the molecular
formula C32H58O13 (Figs. 1 and 2).
In each experiment, rather than one single Rha-C10-C10
or Rha2-C10-C10 structure being produced by the microor-
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ganism, a range containing different amounts of deuterium
incorporation were observed. The range of deuterium ions
was calculated from the m/z difference between the
deuterated and protonated structures and has a lower and
upper limit depending on the number of different deuterium
structures produced for each rhamnolipid. Only those above
a 25% relative abundance in relation to the highest
abundant structure are recorded. In each experiment, the
middle of this range was also the most abundant ion
observed, and this value was used to calculate the
percentage deuterium incorporated. The lowest percentage
of deuterium of 16–17% was observed for the experiment
using 25% heavy water and protonated glycerol as the
carbon sources. While the highest level of around 90%
Table 1 Production of d-rhamnolipids using combinations of deuterated water and/or carbon sources
Deuterium/carbon source Rhamnolipid structure Range of d-ions (m/z) Average (main) % d-atoms Sugar Lipid
d-tetradecane Rha2-C10-C10 677 (28d)–683 (34d) 680 (31d) 54 311 (2d) 368 (29d)
Rha-C10-C10 531 (28d)–536 (33d) 534 (31d) 66 164 (1d) 369 (30d)
50% D2O + d-tetradecane Rha2-C10-C10 684 (35d)–694 (45d) 690 (41d) 72 317 (8d) 371 (32d)
Rha-C10-C10 534 (31d)–544 (41d) 539 (36d) 77 169 (5d) 370 (31d)
100% D2O + h-tetradecane Rha2-C10-C10 666 (17d)–671 (22d) 669 (20d) 35 324 (15d) 344 (5d)
Rha-C10-C10 514 (11d)–518 (15d) 516 (13d) 28 172 (9d) 343 (4d)
50% D2O + h-tetradecane Rha2-C10-C10 656 (7d)–664 (15d) 659 (10d) 18 316 (7d) 341 (2d)
Rha-C10-C10 507 (4d)–512 (9d) 510 (7d) 15 168 (5d) 341 (2d)
25% D2O + h-glycerol Rha2-C10-C10 655 (6d)–662 (12d) 658 (9d) 16 311 (2d) 346 (7d)
Rha-C10-C10 508 (5d)–514 (8d) 508 (8d) 17 164 (1d) 346 (7d)
50% D2O + h-glycerol Rha2-C10-C10 661 (12d)–670 (21d) 666 (17d) 28 312 (3d) 352 (13d)
Rha-C10-C10 513 (10d)–522 (19d) 518 (15d) 32 165 (2d) 351 (12d)
75% D2O + h-glycerol Rha2-C10-C10 672 (23d)–680 (31d) 676 (27d) 47 315 (6d) 359 (20d)
Rha-C10-C10 524 (21d)–530 (27d) 527 (24d) 51 166 (3d) 359 (20d)
90% D2O + h-glycerol Rha2-C10-C10 679 (30d)–689 (40d) 684 (35d) 61 317 (8d) 366 (27d)
Rha-C10-C10 531 (28d)–539 (36d) 535 (32d) 68 168 (5d) 366 (27d)
100% D2O + h-glycerol Rha2-C10-C10 687 (38d)–693 (44d) 690 (41d) 72 318 (9d) 371 (32d)
Rha-C10-C10 537 (34d)–543 (40d) 540 (37d) 79 167 (4d) 371 (32d)
d-glycerol Rha2-C10-C10 658 (9d)–664 (15d) 661 (12d) 21 316 (7d) 344 (5d)
Rha-C10-C10 508 (5d)–514 (11d) 511 (7d) 15 166 (3d) 343 (4d)
100% D2O + d-glycerol Rha2-C10-C10 698 (49d)–702 (53d) 700 (51d) 89 326 (17d) 373 (34d)
Rha-C10-C10 544 (41d)–548 (45d) 546 (43d) 91 172 (9d) 373 (34d)
Only the main dirhamnolipid, Rha2-C10-C10 (fully protonated m/z of 649) and the main monorhamnolipid, Rha-C10-C10, (fully protonated m/z of
503) are displayed. HPLC–MS results are displayed showing the range of deuterated compounds produced, the percentage incorporation of
deuturium and their relative position within the structure
Table 2 Production of d-sophorolipids using combinations of deuterated water and/or carbon sources
Deuterium/carbon source Sophorolipid structure Range of d-ions (m/z) Average (main) % d-atoms Lipid
50% D2O A, 2 Ac, C18:1 709 (4d)–717 (12d) 713 (8d) 14 299 (2d)
L, 2 Ac, C18:1 691 (4d)–699 (12d) 695 (8d) 15 299 (2d)
d-isostearic acid A, 2 Ac, C18:1 740 (35d)–742 (37d) 741 (36d) 63 331 (34d)
L, 2 Ac, C18:1 722 (35d)–724 (37d) 723 (36d) 65 331 (34d)
D2O + oleic acid A, 2 Ac, C18:1 714 (7d)–722 (17d) 718 (13d) 23 298 (1d)
L, 2 Ac, C18:1 695 (7d)–703 (16d) 699 (13d) 24 298 (1d)
D2O + disostearic acid A, 2 Ac, C18:1 749 (34d)–759 (44d) 755 (40d) 89 331 (34d)
L, 2 Ac, C18:1 731 (44d)–740 (53d) 737 (50d) 93 331 (34d)
Only the main lactonic sophorolipid with two acetyl groups and a C18:1 lipid chain (fully protonated m/z of 687) and the main acidic sophorolipid
with two acetyl groups and a C18:1 lipid chain (fully protonated m/z of 705) are displayed. HPLC–MS results are displayed showing the range of
dueterated compounds produced, the percentage incorporation of deuturium and the amount located on the lipid chain
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deuterium was obtained using 100% D2O and d-glycerol, with
increasing use of heavy water from 25% to 100%, there was
an increase in the level of deuterium within the rhamnolipid
structures from, on average, nine and eight d-atoms for the
Rha2-C10-C10 and Rha-C10-C10, respectively, to 41 and 37 d-
atoms. During each analysis, data-dependant tandem MS
fragmentation was carried out, which assisted in determining
the relative positions of the d-atoms within the chemical
structure. However, in some experiments, one deuterium atom
is left unaccounted, which would suggest that when the
structure fragments, the new site for ionisation was most
probably deuterated. In the case of rhamnolipids, one of the
fragmentations observed was the breakage of the bond between
the sugar and lipidic moiety, thus helping to identify the relative
position of the deuterium atoms. When d-tetradecane and H2O
was the sole carbon source used, virtually all the deuterium
was present on the lipid chain. However, production using h-
tetradecane and D2O resulted in the majority being present on
the sugar moiety, with 4/5 d-atoms on the lipid chain.
Production of deuterated rhamnolipids using protonated
glycerol and an increasing percentage of heavy water
resulted in rising levels of d-atom incorporation on the
lipid chain from 13 to 32 d-atoms, while the rhamnose
portion also increased. When the only source of deuterium
was present in glycerol, only 4/5 d-atoms were incorporated
on the fatty acid portion with the remainder present on the
sugar group, suggesting that when no alkane or fatty acid is
present during production, water is heavily involved in the
biosynthesis of the lipid portion. The production using both
D2O and d-glycerol resulted in the greatest level of
deuterated rhamnolipids with 34 d-atoms on the lipid chain
and 17 and nine d-atoms on the dirhamnose and mono-
rhamnose moieties, respectively. The use of mixtures of
heavy and normal water along with protonated or deuter-
ated carbon source resulted in a large range of d-atoms
incorporated. For example, when 50/50 heavy and normal
water was used with d-tetradecane, the range of d-atoms for
each type of rhamnolipid was 10. The use of 100% D2O and
d-glycerol resulted in a range of four different levels for each
rhamnolipid product, suggesting the use of highly pure
carbon sources and water results in a much less complex
mixture of rhamnolipids being produced.
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Fig. 1 HPLC–MS showing the TIC spectrum of d-rhamnolipids
produced using 50/50 water/heavy water and protonated glycerol.
Each of the major rhamnolipids is represented by a bell-shaped peak
with each line representing the same structure with one more or less d-
atoms present
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Generally, the production of sophorolipids results in an
even more complex mixture being produced, containing
anywhere from 20 to 40 different sophorolipids and associated
isomers. The sophorolipids produced can be split into two
groups, acidic and lactonic, with only the main acidic and
lactonic forms displayed in Table 2. The main acidic,
17-L-[(2′-O-β-D-glucopyranosyl-β-D-glucopyranosyl)-
oxy]octadecenoic acid- 6′, 6′′-diacetate, has a molecular
formula of C34H57O15 giving an [M–H]
− signal at m/z 705
in the fully protonated form. Under negative mode
ionisation, the main lactonic, 17-L-[(2′-O-β-D-glucopyranosyl-
β-D-glucopyranosyl)-oxy]octadecenoicacid-1,4″-lactone-6′,6″-
diacetate, gives a signal at m/z 687 corresponding to the
molecular formula C34H55O14 minus one proton, which
occurs during ionisation. During MS/MS fragmentation, only
the ion representing the fatty acid portion could be detected
and only at a low abundance compared to other major
fragments that were present.
Using 50% heavy water and no fatty acid carbon sources
resulted in an extremely small quantity of d-sophorolipids
being produced with two d-atoms incorporated in the lipid
chain and another six d-atoms presumably on the sugar
moiety. With 100% D2O and oleic acid, 13 d-atoms were
present with 12 on the sophorose group. Unlike d-
rhamnolipid where the water source was capable of influenc-
ing the level of deuterium incorporated into the lipidic chain,
no such effect was observed for d-sophorolipid biosynthesis.
Direct incorporation of deuterium into the fatty acid
portion was achieved using deuterated isostearic acid,
resulting in 34 d-atoms being present, with only two d-
atoms in the sugar portion when normal water was also
used. Cultivation using heavy water and d-isostearic acid
resulted in roughly 90% deuterium being present in each
main structure with 34 and 16 d-atoms on the lipid and
sugar portions, respectively.
Rhamnolipid gene resequencing from adapted strain
and comparison with wild-type strain
Direct comparison of the complete gene sequences for RhlB
(the mono-rhamnosyl transferase) and RhlC (the di-
rhamnosyl transferase) in the deuterium adapted strain
AD7-d, and its parent strain AD7 showed that there had
been no genetic modification of two of the key genes
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Fig. 2 HPLC-MS showing the TIC spectrum of d-rhamnolipids produced using 100% D20 and d-glycerol, showing a much smaller range of d-
atoms for each structure
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involved in rhamnolipid synthesis; therefore, the adaptation
process had almost certainly been metabolic adaptation.
The accession numbers for the gene sequences for strain
AD7 are RhlB FN601361 and RhlC FN601388.
Discussion
The initial target for this work was the production of
rhamnolipids and sophorolipids with high levels of deuter-
ation (at least 50%) that could be used for neutron
scattering studies of the surface adsorption properties of
the biosurfactants. As the work progressed, using D2O and
other deuterated carbon sources, we realised that the
incorporation patterns in the biosurfactants could be
manipulated through judicious use of D2O and the other
substrates. Two clear conclusions can be drawn from the
experiments carried out. First, when high levels of
deuterium are provided to prokaryotes, either in the form
of D2O or deuterated carbon substrate, high levels of initial
inhibition of growth occur. This inhibition can be overcome
by adopting a progressive adaptation strategy so that
eventually, although growth is still restricted, satisfactory
levels of production can be achieved. The adaptation of the
prokaryotes is metabolic and does not appear to be based in
genetic modification of the key genes in the metabolic
pathway. This is of significant importance as it means that
there are no changes in the key metabolic pathway
products. Eukaryotic microorganisms do not suffer the
same level of deuterium inhibition as prokaryotes although
adaptation may still be necessary to achieve effective
growth (Haon et al. 1993; Morgan et al 2000). Kushner et
al. (1997) stated ‘mechanisms involved in such adaptation
have hardly been studied’ and the situation appears to be
largely unchanged at the present time. Paliy et al (2003)
recognised that the adaptation of Escherichia coli to growth
on deuterated minimal medium could not be clearly
identified as solely due to metabolic adaptation or genetic
mutation but suggested that a range of non-specific
mutations were involved in the process.
The second conclusion is that careful selection of
deuterated substrates can be used to achieve selective
labelling of products. In the case of the biosurfactants,
which consist of a hydrophilic portion comprising sugar
molecules and a hydrophobic tail composed of lipid chains,
the sugar portion can be effectively labelled with the use of
D2O only while the lipid chains can be heavily labelled
using an appropriate deuterated carbon substrate. These
results together indicate the feasibility of production of
deuterated bioactive microbial products in which the exact
pattern of labelling could be manipulated to give optimum
efficacy. In the case of biosurfactants with wide potential
medical application (Rodrigues et al. 2006, 2007), this may
have significant implications with regards to persistence
and or efficacy in the human body.
Wider implications of the ability to manipulate the level
of deuteration in various bioactive molecules such as
antibiotics and other drugs is modifying the physicochem-
ical structures of such compounds which may lead to
different efficacy, persistence or increased challenges to the
development of microbial resistance. An area of great
future interest we believe will be determining whether site
directed, selective or specifically deuterated antibiotics are
an effective strategy against drug-resistant microorganisms.
Partial success of improved effectiveness compared to the
protonated forms against sensitive organisms would lead to
the ability to use lower doses and higher efficiency against
resistant organisms. Achieving the latter would open vast
area of research and industrial interest in the use of
deuterated compounds in numerous biomedical and health
related applications.
Other potential uses include selective labelling of parts
of target drugs to monitor their breakdown or dissociation
within biological systems. Both naturally existing microbial
products and other new products can be produced using
deuterated water and substrate. Eguchi et al. (2005)
produced deuterated zeaxanthin, lycopene and β-carotene
using a genetically engineered E. coli on deuterated
mevalonate as one of the growth substrates to study the
physicochemical properties of these substrates. Finally, the
increased availability of highly deuterated microbial bioac-
tive compounds may encourage research activity into their
monitoring, biochemistry, durability, developing resistance
and therefore, possibly extend their uses.
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